Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071669 · ClinicalTrials.gov registry record · Phase 2
Acupuncture as a Supplemental Treatment for Bipolar Depression
A Phase 2 study of Bipolar Disorder, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00071669: Completed Phase 2 study of Bipolar Disorder, sponsored by University of Texas Southwestern Medical Center.
NCT00071669 is a Phase 2 study of Bipolar Disorder that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00071669, a Phase 2 study of Bipolar Disorder, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effectiveness of acupuncture in the treatment of Bipolar Depression.
Conditions Studied
Interventions
- PROCEDURE Acupuncture
Study Locations (1)
Texas
- Bipolar Disorder Clinic and Research Program - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2001-11 |
| Phase | Phase 2 |
What the finished NCT00071669 record still lists
NCT00071669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 333-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.
NCT00071669 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00071669 about?
NCT00071669 is a clinical study titled "Acupuncture as a Supplemental Treatment for Bipolar Depression". The purpose of this study is to evaluate the effectiveness of acupuncture in the treatment of Bipolar Depression.
What is the current status of trial NCT00071669?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2001-11.
What conditions does trial NCT00071669 study?
This clinical trial studies the following conditions: Bipolar Disorder.
What interventions are being tested in trial NCT00071669?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00071669?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00071669 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00071669's enrollment target sits among peer trials
30 136th of 162 higher than 18 of 162 other Bipolar Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
RECRUITING · Phase 2
-
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
RECRUITING · Phase 2
-
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
RECRUITING · Phase 2
-
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia